FHIR © HL7.org  |  Server Home  |  XIG Home  |  Server Source  |  FHIR  

FHIR IG Statistics: FHIR Resources

ValueSets

31,116 resources

Source: Text:

By Version

By Authority

By Realm

 

Start Prev Rows 3400 - 3600 Next

PackageVersionIdentityName/TitleStatusFMMWGDateRealmAuthSource(s)
us.nlm.vsacR42.16.840.1.113762.1.4.1166.173Contraceptive Implant HCPCS Devicesactive2021-10ushl7cms
us.nlm.vsacR42.16.840.1.113762.1.4.1166.174Contraceptive Patch Devicesactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1166.177Live Birth Delivery Proceduresactive2024-09ushl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1166.178Contraceptive Ring Surveillanceactive2021-10ushl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1166.180Contraceptive Implant CPT Provision Proceduresactive2021-10ushl7cpt
us.nlm.vsacR42.16.840.1.113762.1.4.1166.181Injectable Contraceptive SNOMED Surveillance Proceduresactive2021-10ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1166.182Injectable Contraceptive SNOMED Provision Proceduresactive2021-10ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1166.183Injectable Contraceptive SNOMED Findingsactive2021-10ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1166.185Injectable Contraceptive ICD10CM Provision Encountersactive2021-10ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1166.186Injectable Contraceptive ICD10CM Surveillanceactive2021-10ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1166.187Injectable Contraceptive HCPCS Provision Proceduresactive2021-10ushl7cms
us.nlm.vsacR42.16.840.1.113762.1.4.1166.188Injectable Contraceptive LOINCactive2021-10ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1166.189Oral Contraceptive Pill SNOMED Surveillance Proceduresactive2021-10ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1166.190Oral Contraceptive Pill SNOMED Provision Proceduresactive2021-10ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1166.191Oral Contraceptive Pill SNOMED Findingsactive2021-10ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1166.193Oral Contraceptive Pill ICD10CM Provision Encountersactive2021-10ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1166.194Oral Contraceptive Pill ICD10CM Surveillanceactive2021-10ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1166.195Oral Contraceptive Pill HCPCS Provision Proceduresactive2021-10ushl7cms
us.nlm.vsacR42.16.840.1.113762.1.4.1166.196Oral Contraceptive Pill LOINCactive2021-10ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1166.197Injectable Contraceptive Provision Proceduresactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1166.198Injectable Contraceptive Surveillanceactive2021-10ushl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1166.199Oral Contraceptive Pill Provision Proceduresactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1166.200Oral Contraceptive Pill Surveillanceactive2021-10ushl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1166.201Contraceptive Implant Devicesactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1166.202Contraceptive Implant Provision Proceduresactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1166.203Contraceptive Implant Surveillanceactive2021-10ushl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1166.96Infecund Not for Contraceptive Reasons SNOMED Findingsactive2021-10ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1170.10ASN Screening Declinedactive2024-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1170.2Intracranial or Intraspinal surgeryactive2022-02ushl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1170.22Emergency Department Observationactive2024-09ushl7cpt
us.nlm.vsacR42.16.840.1.113762.1.4.1170.27Mental Health Diagnosis without Substance Use Disordersactive2025-02ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1170.28Mental Health Diagnosis without Substance Use Disordersactive2025-02ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1170.29Bed Assignedactive2024-05ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1170.3Malignant Intracranial Neoplasm Groupactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1170.31Healthcare Agent & Power of Attorney Documentationactive2024-10ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1170.32Healthcare Agent and Power of Attorney Documentationactive2024-09ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1170.33Advance Directive Documentationactive2024-10ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1170.34Advance Directive Documentationactive2024-11ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1170.35Advance Directive Documentationactive2024-09ushl7cpt
us.nlm.vsacR42.16.840.1.113762.1.4.1170.36Portable Medical Order(s) Documentationactive2024-10ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1170.37Portable Medical Order(s) Documentationactive2024-09ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1170.38Advance Care Planning Discussion Documentationactive2024-11ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1170.4Thrombolytic medicationsactive2021-10ushl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1170.40Advance Care Planning Documentationactive2024-09ushl7cpt
us.nlm.vsacR42.16.840.1.113762.1.4.1170.41Advance Care Planning Documentationactive2024-09ushl7cms
us.nlm.vsacR42.16.840.1.113762.1.4.1170.42Healthcare Agent & Power of Attorney Documentationactive2024-10ushl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1170.43Advance Directive Documentationactive2024-10ushl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1170.45Advance Care Planning Documentationactive2024-11ushl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1170.46Advance Care Planning Documentationactive2024-10ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1170.47Portable Medical Order(s) Documentationactive2024-10ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1170.48Portable Medical Order(s) Documentationactive2024-10ushl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1170.49Intervention for Positive Utility Insecurity Screenactive2024-11ushl7cms
us.nlm.vsacR42.16.840.1.113762.1.4.1170.5Allergy to thrombolyticsactive2025-02ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1170.50Intervention for Positive Utility Insecurity Screenactive2024-11ushl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1170.51Intervention for Positive Transportation Insecurity Screenactive2024-11ushl7cms
us.nlm.vsacR42.16.840.1.113762.1.4.1170.52Intervention for Positive Transportation Insecurity Screenactive2024-11ushl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1170.53Intervention for Positive Housing Instability Screenactive2024-11ushl7cms
us.nlm.vsacR42.16.840.1.113762.1.4.1170.54Intervention for Positive Housing Instability Screenactive2024-11ushl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1170.55Intervention for Positive Homelessness Screenactive2024-11ushl7cms
us.nlm.vsacR42.16.840.1.113762.1.4.1170.56Intervention for Positive Homelessness Screenactive2024-11ushl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1170.57Non Invasive Oxygen Therapy Device Codesactive2025-02ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1170.58Goals, preferences, and priorities for medical treatmentactive2025-04ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1170.6Thrombolytics Adverse Eventactive2025-02ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1170.7Intraspinal surgeryactive2024-02ushl7cms
us.nlm.vsacR42.16.840.1.113762.1.4.1176.58Food Insecurity Screening Positiveactive2023-10ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1178.1Ezetimibe Therapyactive2023-02ushl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1178.10Antihypertensive Medicationsactive2024-02ushl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1178.100Allergy or Intolerance to ACE Medicationactive2024-11ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1178.101Allergy or Intolerance to ARB Medicationactive2024-11ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1178.102Chronic Kidney Disease Stage 1active2024-12ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1178.103Chronic Kidney Disease Stage 2active2024-12ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1178.104Chronic Kidney Disease Stage 3active2024-12ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1178.105Chronic Kidney Disease Stage 4active2024-12ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1178.106Chronic Kidney Disease Stage 5active2024-12ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1178.107ICD10 CM Chronic Kidney Disease Stage 1active2024-12ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1178.108ICD10 CM Chronic Kidney Disease Stage 2active2024-12ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1178.111AHA GWTG Chronic Kidney Disease Stage 2active2024-11ushl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1178.112ICD10 CM Chronic Kidney Disease Stage 3active2024-12ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1178.113ICD10 CM Chronic Kidney Disease Stage 4active2024-12ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1178.114ICD10 CM Chronic Kidney Disease Stage 5active2024-12ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1178.115AHA GWTG Chronic Kidney Disease Stage 1active2024-11ushl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1178.116AHA GWTG Chronic Kidney Disease Stage 3active2024-11ushl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1178.117AHA GWTG Chronic Kidney Disease Stage 4active2024-11ushl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1178.118SNOMED CT Atrial Fibrillationactive2024-12ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1178.119ICD10 CM Atrial Fibrillationactive2024-12ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1178.121AHA GWTG Atrial Fibrillationactive2024-11ushl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1178.123SNOMED CT Hyperlipidemiaactive2024-12ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1178.124ICD10 CM Hyperlipidemiaactive2024-12ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1178.125AHA GWTG Hyperlipidemiaactive2024-11ushl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1178.126SNOMED CT Hypertriglyceridemiaactive2024-12ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1178.127ICD10 CM Hypertriglyceridemiaactive2024-12ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1178.129AHA GWTG Hypertriglyceridemiaactive2024-11ushl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1178.130SNOMED CT Gestational Diabetesactive2024-12ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1178.131ICD10 CM Gestational Diabetesactive2024-12ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1178.132AHA GWTG Gestational Diabetesactive2024-11ushl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1178.133SNOMED CT Hyperglycemiaactive2024-12ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1178.134ICD10 CM Hyperglycemiaactive2024-12ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1178.135AHA GWTG Hyperglycemiaactive2024-11ushl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1178.136SNOMED CT Nonobstructive CADactive2024-12ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1178.137ICD10 CM Nonobstructive Coronary Artery Diseaseactive2024-12ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1178.138AHA GWTG Nonobstructive coronary artery diseaseactive2024-11ushl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1178.139AHA GWTG Anti Obesity Pharmacotherapyactive2024-12ushl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1178.15Non Tobacco Smoking Product Useractive2024-02ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1178.16Antihypertensive Fixed Dose Combination Medicationsactive2024-02ushl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1178.2PCSK9 Inhibitorsactive2023-02ushl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1178.20CCB and Thiazide and Thiazide Like Diureticsactive2021-01ushl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1178.21Referral to cardiac rehabactive2021-04ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1178.22Cardiac Rehabilitationactive2021-04ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1178.252 Hour Blood Glucose Testactive2022-07ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1178.26NYHA Functional Classificationactive2022-07ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1178.27ARNI Therapyactive2022-07ushl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1178.29MRA Therapyactive2022-07ushl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1178.3Cholesterol non HDL Laboratory Testactive2021-04ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1178.30SGLT2 Inhibitorsactive2024-02ushl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1178.31Heart Transplantactive2022-02ushl7cpt
us.nlm.vsacR42.16.840.1.113762.1.4.1178.32Heart Transplantactive2022-02ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1178.33Heart Transplantactive2022-02ushl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1178.34Allergy to MRA Therapyactive2024-02ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1178.35Aspirin or Clopidogrelactive2024-02ushl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1178.39Cardiac Rehabilitationactive2024-01ushl7cpt
us.nlm.vsacR42.16.840.1.113762.1.4.1178.4Hypothyroidismactive2021-04ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1178.40Cardiac Rehabilitationactive2022-07ushl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1178.43SGLT2 Ingredientsactive2022-07ushl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1178.44MRA Ingredientsactive2022-07ushl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1178.49Minnesota Living with Heart Failure Questionnaireactive2022-07ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1178.5Hypothyroidismactive2024-02ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1178.50Kansas City Cardiomyopathy Questionnaireactive2022-07ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1178.51Cardiac Paceractive2021-11ushl7cms
us.nlm.vsacR42.16.840.1.113762.1.4.1178.52Cardiac Paceractive2025-01ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1178.53Cardiac Paceractive2022-02ushl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1178.54Heart Transplant Complicationsactive2022-03ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1178.55Heart Transplant Complicationsactive2025-01ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1178.56Heart Transplant Complicationsactive2022-03ushl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1178.57Left Ventricular Assist Device Complicationsactive2022-02ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1178.58Left Ventricular Assist Device Complicationsactive2022-02ushl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1178.59Left Ventricular Assist Device Placementactive2023-02ushl7cms
us.nlm.vsacR42.16.840.1.113762.1.4.1178.6Hypothyroidismactive2021-04ushl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1178.60Left Ventricular Assist Device Placementactive2023-02ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1178.61Left Ventricular Assist Device Placementactive2022-02ushl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1178.62Left Ventricular Assist Device Placementactive2022-02ushl7cpt
us.nlm.vsacR42.16.840.1.113762.1.4.1178.63Heart Transplantactive2022-07ushl7cms
us.nlm.vsacR42.16.840.1.113762.1.4.1178.65Cardiac Paceractive2022-11ushl7cpt
us.nlm.vsacR42.16.840.1.113762.1.4.1178.66Diastolic Heart Failureactive2023-06ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1178.67Diastolic Heart Failureactive2023-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1178.68Diastolic Heart Failureactive2022-02ushl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1178.69Allergy to SGLT2 Inhibitorsactive2023-02ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1178.7Anorexia Nervosaactive2023-02ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1178.70Intolerance to SGLT2 Inhibitorsactive2022-07ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1178.71Intolerance to MRA Therapyactive2022-07ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1178.72ARNI Ingredientactive2022-02ushl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1178.73Mitral Stenosisactive2022-02ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1178.74Mitral Stenosisactive2022-02ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1178.75Mitral Stenosisactive2022-02ushl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1178.76Mechanical Prosthetic Heart Valveactive2022-11ushl7cpt
us.nlm.vsacR42.16.840.1.113762.1.4.1178.77Mechanical Prosthetic Heart Valveactive2025-04ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1178.78Mechanical Prosthetic Heart Valveactive2022-02ushl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1178.79Mechanical Prosthetic Heart Valve in Situactive2022-02ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1178.8Anorexia Nervosaactive2021-04ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1178.82Systolic Heart Failureactive2023-03ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1178.83Systolic Heart Failureactive2023-03ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1178.84Systolic Heart Failureactive2023-03ushl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1178.85Carotid Interventionactive2023-03ushl7cpt
us.nlm.vsacR42.16.840.1.113762.1.4.1178.86Serum Creatinineactive2023-10ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1178.87Urine Creatinineactive2025-03ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1178.88Urine Albuminactive2023-10ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1178.9Anorexia Nervosaactive2021-04ushl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1178.90Non Steroidal Mineralcorticoid Receptor Antagonistactive2024-10ushl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1178.91Glucagon like peptide 1 medicationsactive2024-11ushl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1178.96AHA GWTG Long COVID19active2024-10ushl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1181.1Wound internal item and/or body structure visible value set (foundation metadata concept)active2024-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1181.11Wound exudate appearance value set (foundation metadata concept)active2024-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1181.12Wound exudate color value set (foundation metadata concept)active2024-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1181.13Exudate odor value set (foundation metadata concept)active2024-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1181.16Skin temperature value set (foundation metadata concept)active2024-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1181.17Skin color enumerated value set (foundation metadata concept)active2024-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1181.18Skin turgor value set (foundation metadata concept)active2024-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1181.19Skin and mucous membrane integrity value set (foundation metadata concept)active2024-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1181.2Periwound condition value set (foundation metadata concept)active2024-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1181.20Skin moisture value set (foundation metadata concept)active2024-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1181.3Wound Type Etiology value setactive2024-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1181.4Wound episode value set (foundation metadata concept)active2024-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1181.6Wound bed appearance value set (foundation metadata concept)active2024-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1181.60Wound type reference setactive2024-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1181.7Wound bed color value set (foundation metadata concept)active2024-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1181.74Nonverbal pain indicators reference setactive2024-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1181.76Pain associated signs and symptoms reference setactive2024-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1181.77Pain body location reference setactive2024-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1181.8Wound edge description value set (foundation metadata concept)active2024-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1181.80Pain quality reference setactive2025-03ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1181.81Pain speed of onset reference setactive2024-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1181.9Presence absence value set (foundation metadata concept)active2018-07ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1186.1Common drug substances for allergy and intolerance documentationactive2024-06ushl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1186.2Common drug classes for allergy and intolerance documentationactive2024-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1186.3Common dietary substances for allergy and intolerance documentationactive2024-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1186.4Common environmental substances for allergy and intolerance documentationactive2024-06ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1190.10NHSNCriterionOfDiagnosisCode(CDCNHSN)active2020-08ushl7cdc
us.nlm.vsacR42.16.840.1.113762.1.4.1190.11NHSNCriterionOfDiagnosisCode(SNOMEDCT)active2020-08ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1190.12NHSNInfectionConditionCode(CDCNHSN)active2020-08ushl7cdc
us.nlm.vsacR42.16.840.1.113762.1.4.1190.13NHSNInfectionConditionCode(SNOMEDCT)active2020-08ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1190.14NHSNInfectionTypeCode(CDCNHSN)active2020-08ushl7cdc